Search All News
Leading physician and researcher, Lisa Kachnic, MD, will lead Columbia's department of radiation oncology.
Anil Rustgi, the new director of the Herbert Irving Comprehensive Cancer Center, talks about new ideas in cancer research, the best patient care, and the importance of physician-scientists.
A clinical trial at Columbia and other centers found that patients responded to a new “smart drug” for women with an aggressive form of breast cancer.
- December 8, 2014
Richard D. Carvajal, MD, has been named director of the Experimental Therapeutics/Phase I program and melanoma service in medical oncology at NewYork-Presbyterian/Columbia University Medical Center, effective Nov. 1, 2014.
- November 12, 2014
Daniel Seidman, author of “Smoke-Free in 30 Days,” will participate in a blogtalkradio show Nov. 17 in advance of this year’s Great American Smokeout on Nov. 20.
- October 27, 2014
A CUMC study found that the use of generic aromatase inhibitors, which cost considerably less than their brand-name counterparts, increased treatment adherence by 50 percent.
- October 9, 2014
Using an innovative algorithm, CUMC researchers have found that loss of a gene called KLHL9 is the driving force behind the most aggressive form of glioblastoma, the most common form of brain cancer.
- August 27, 2014
The Herbert Irving Comprehensive Cancer Center is one of only two NCI-designated Comprehensive Cancer Centers in New York City and one of only three in New York State.
- August 26, 2014
Columbia surgeons and radiation oncologists deliver precise radiotherapy immediately following cancer tumor removal.
- August 20, 2014
Research from Columbia shows that nerves play a critical role in stomach cancer growth and blocking nerve signals using surgery or Botox® could provide an effective therapy for the disease.
- July 30, 2014
Columbia experts worked together to offer an innovative option to a pregnant woman needing radiation therapy for a fast-growing brain tumor.
- July 22, 2014
Patients considering morcellation should be counseled about the prevalence of cancerous and precancerous conditions prior to undergoing the procedure.